METTL3 and proliferative vitreoretinopathy: METTL3-mediated m6A modification of RNAs has a non-negligible role in eye-related diseases, such as proliferative vitreoretinopathy (Wang, Doxtader & Nam, 2016) and diabetes-induced pericyte dysfunction (Suo et al., 2022).